glp-1 agonists for diabetes GLP-1 Agonists: A Comprehensive Overview

Tirzepatide was approved by the Food and Drug Administration in May 2022 for the treatment of T2D, and later in October received Fast Track designation for treatment of obesity

American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on GLP-1 receptor agonists

adults in English and in Spanish

3.3 Long-acting GLP1 receptor agonists: Once-weekly 3.3.1 Semaglutide SMG is an analog of long-acting GLP-1, mainly used to control T2DM, and is also suitable for promoting weight loss in people with mild obesity (95, 96)

Ozempic: The Diabetes Medication with Weight Loss Benefits Ozempic was originally developed to help manage type 2 diabetes, and it does that job extremely well